Related Experiment Video
Updated: May 22, 2026

Rectal Organoid Morphology Analysis (ROMA): A Diagnostic Assay in Cystic Fibrosis
Published on: June 10, 2022
Functional defecation disorders in children: comparing the Rome II with the Rome III criteria
Rosa Burgers1, Alon D Levin, Carlo Di Lorenzo
1Emma Children's Hospital, Academic Medical Center, Amsterdam, The Netherlands. r.e.burgers@amc.nl
Insights
The Rome III criteria identify more pediatric functional defecation disorders (FDD) than Rome II criteria. Rome III criteria are an advancement for diagnosing FDD in children, with functional constipation (FC) being more prevalent.
Area of Science:
- Pediatric Gastroenterology
- Clinical Research
- Diagnostic Criteria Evaluation
Background:
- Functional defecation disorders (FDD) are common in children.
- Accurate diagnosis relies on standardized criteria, such as the Rome criteria.
- Previous versions of Rome criteria may have limitations in capturing the full spectrum of pediatric FDD.
Purpose of the Study:
- To determine the prevalence of pediatric FDD using Rome III criteria.
- To compare FDD prevalence between Rome III and Rome II criteria.
- To assess the impact of Rome III criteria on the diagnosis of functional constipation (FC) and functional fecal incontinence (FFI) in children.
Main Methods:
- Chart review of patients referred to a tertiary outpatient clinic for constipation and/or fecal incontinence.
- Standardized bowel questionnaires and physical examinations, including rectal examination, were administered.
- Prevalence of pediatric FDD was calculated using both Rome II and Rome III criteria.
Main Results:
- Out of 336 patients with FDD, 87% met Rome III criteria for functional constipation (FC), compared to only 34% meeting Rome II criteria for FC or functional fecal retention (P < .001).
- Fecal incontinence was present in 75% of patients, and 49% had a palpable rectal fecal mass.
- Functional nonretentive fecal incontinence was diagnosed in 11% of patients by both criteria sets.
Conclusions:
- The Rome III criteria for pediatric FC are less restrictive than Rome II criteria.
- Rome III criteria represent a significant improvement in defining and recognizing FDD in children.
- The findings support the broader application of Rome III criteria for accurate FDD diagnosis.
Objectives:
To evaluate the prevalence of pediatric functional defecation disorders (FDD) using the Rome III criteria and to compare these data with those obtained using Rome II criteria.
Study Design:
A chart review was performed in patients referred to a tertiary outpatient clinic with symptoms of constipation and/or fecal incontinence. All patients received a standardized bowel questionnaire and physical examination, including rectal examination. The prevalence of pediatric FDD according to both Rome criteria sets was assessed.
Results:
Patients with FDD (n = 336; 61% boys, mean age 6.3 ± 3.5 SD) were studied: 39% had a defecation frequency ≤ 2/wk, 75% had fecal incontinence, 75% displayed retentive posturing, 60% had pain during defecation, 49% passed large diameter stools, and 49% had a palpable rectal fecal mass. According to the Rome III criteria, 87% had functional constipation (FC) compared with only 34% fulfilling criteria for either FC or functional fecal retention based on the Rome II definitions (P < .001). Of the patients with a rectal fecal mass, 95% would also have been correctly identified as having FC without a rectal examination. Twenty-nine patients (11%) fulfilled the criteria for functional nonretentive fecal incontinence according to both the Rome II and Rome III criteria.
Conclusion:
The pediatric Rome III criteria for FC are less restrictive than the Rome II criteria. The Rome III criteria are an important step forward in the definition and recognition of FDD in children.
Related Concept Videos
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Assessment of the Rectum and Anus
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and solid...
Oppositional Defiant Disorder
Diagnostic Criteria and...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Irritable Bowel Syndrome III: Medical and Nursing Management
